Stock market today: Dow, S&P 500, Nasdaq futures slip after US GDP unexpectedly accelerates

Company and Industry Insights - Novo Nordisk's US-listed stock experienced a significant increase in premarket trading after receiving official US approval to market its Wegovy weight-loss pill [5] - The US economy demonstrated strong resilience with a reported GDP growth of 4.3% annualized rate in Q3, surpassing the expected 3.3%, indicating robust consumer spending [4] - The upcoming consumer confidence data from the Conference Board is anticipated to provide insights into the K-shaped economy affecting American shoppers, which is a key narrative for 2025 [5]